Paul Cheng
About
In The Last Decade
Paul Cheng
11 papers receiving 479 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 402
- Hematology 206
- Molecular Biology 117
- Orthopedics and Sports Medicine 90
- Pathology and Forensic Medicine 59
Countries citing papers authored by Paul Cheng
This map shows the geographic impact of Paul Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Cheng more than expected).
Fields of papers citing papers by Paul Cheng
This network shows the impact of papers produced by Paul Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Cheng. The network helps show where Paul Cheng may publish in the future.
Co-authorship network of co-authors of Paul Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Cheng. A scholar is included among the top collaborators of Paul Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Cheng. Paul Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study breakdown → | 307 |
| 3 | 13 | |
| 4 | 94 | |
| 5 | 21 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 10 | |
| 9 | 19 | |
| 10 | 1 | |
| 11 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.